Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.08/Share

Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.08), versus ($0.22) reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

You May Also Be Interested In

• Wells Fargo cuts Netflix rating on engagement risk, weak slate
• Can global equities keep rising? UBS sees these factors driving upside
• Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained